| CAR | Chimeric Antigen Receptor |
| FDA | Food and Drug Administration |
| ICIs | Immune Checkpoint Inhibitors |
| EVs | Extracellular Vesicles |
| MISEV | Minimal Information for Studies of Extracellular Vesicles |
| DNA | Deoxyribonucleic Acid |
| RNA | Ribonucleic Acid |
| ILVs | Intraluminal Vesicles |
| MVEs | Multivesicular Endosomes |
| CD | Cluster of Differentiation |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| NTA | Nanoparticle Tracking Analysis |
| DLS | Dynamic Light Scattering |
| TEM | Transmission Electron Microscopy |
| SEM | Scanning Electron Microscopy |
| ARF6 | ADP-Ribosylation Factor 6 |
| SDS-PAGE | Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis |
| PBP | Polymer-based Precipitation |
| CA125 | Cancer Antigen 125 |
| TME | Tumor Microenvironment |
| TP53 | Tumor Protein p53 |
| CRC | Colorectal Cancer |
| HGS | Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate |
| CSF | Cerebrospinal Fluid |
| PD | Parkinson’s Disease |
| EDIL3 | Epidermal Growth Factor-Like Repeats and Discoidin I-Like Domains 3 |
| EGFR | Epidermal Growth Factor Receptor |
| FAK | Focal Adhesion Kinase |
| CT | Computed Tomography |
| MRI | Magnetic Resonance Imaging |
| CA15-3 | Carcinoma Antigen 15-3 |
| HNSCC | Head and Neck Squamous Cell Carcinoma |
| TGF-β3 | Transforming Growth Factor-beta 3 |
| CRT | Chemoradiation Therapy |
| GWAS | Genome-Wide Association Studies |
| UBC | Urinary Bladder Cancer |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| TAAs | Tumor-Associated Antigens |
| TSAs | Tumor-Specific Antigens |
| MHC | Major Histocompatibility Complex |
| TCRs | T Cell Receptors |
| CD8+ T cells | Cytotoxic T Cells |
| Th cells | CD4+ Helper T Cells |
| APCs | Antigen Presenting Cells |
| DCs | Dendritic Cells |
| BCR | B Cell Receptor |
| MDSCs | Myeloid-Derived Suppressor Cells |
| TAMs | Tumor-Associated Macrophages |
| Tregs | Regulatory CD4+ T Cells |
| NK | Natural Killer |
| M-MDSCs | Monocytic MDSCs |
| PMN-MDSCs | Polymorphonuclear MDSCs |
| STAT | Signal Transducer and Activator of Transcription |
| ER | Endoplasmic Reticulum |
| NF-κB | Nuclear Factor Kappa B |
| cAMP | Cyclic Adenosine Monophosphate |
| IFN | Interferon |
| PTGES | Prostaglandin E Synthase |
| COX-2 | Cyclooxygenase-2 |
| C/EBPβ | CCAAT-Enhancer-Binding Protein-β |
| ARG1 | Arginase 1 |
| iNOS | Inducible Nitric Oxide Synthase |
| ROS | Reactive Oxygen Species |
| VEGF | Vascular Endothelial Growth Factor |
| IL | Interleukin |
| PGE2 | Prostaglandin E2 |
| PD-L1 | Programmed Cell Death-Ligand 1 |
| CCL18 | Chemokine (C-C motif) Ligand 18 |
| ECM | Extracellular Matrix |
| Teffs | Effector T Cells |
| CTLA-4 | Cytotoxic T-Lymphocyte-Associated Protein 4 |
| PD-1 | Programmed Cell Death Protein 1 |
| IFN-γ | Interferon-Gamma |
| PI3K | Phosphatidylinositol 3-Kinase |
| RAS | Rat Sarcoma Virus |
| CTL | Cytotoxic T Lymphocyte |
| Akt | Serine/Threonine Protein Kinase |
| TNF-α | Tumor Necrosis Factor |
| NSCLC | Non-Small Cell Lung Cancer |
| miRNA | MicroRNA |
| LNP | Lipid Nanoparticles |
| Th1 | T-helper Cell Type 1 |
| TRP2 | Tyrosinase-Related Protein 2 |
| IMC | Immature Myeloid Cells |
| SIRPα | Signal Regulatory Protein Alpha |
| circUHRF1 | Circular Ubiquitin-Like with PHD and Ring Finger Domain 1 RNA |
| RGD | Arginine-Glycine-Aspartic Acid |
| MLKL | Mixed Lineage Kinase Domain-Like Protein |
| RIPK3 | Receptor-Interacting Protein Kinase 3 |
| GzmB | Granzyme B |
| FasL | Fas Ligand |
| TIM-3 | T Cell Immunoglobulin and Mucin Domain 3 |
| LAG-3 | Lymphocyte Activation Gene 3 |